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Background:  Patients with aortic stenosis (AS) and left ventricular systolic dysfunction (LVD) represent a high risk group, yet limited risk 
stratification tools exist to allow optimal therapeutic decision making for surgery within this group. We hypothesized that baseline global 
longitudinal strain (GLS) would be an independent predictor of mortality in patients with AS and LVD.
methods:  Baseline GLS was calculated using TomTec software in 309 patients with AS and LVD (LVEF <50%). AS severity was defined by 
Doppler gradient as either moderate (≥25mmHg to <40mmHg or peak velocity ≥3.0m/s to <4.0 m/s) or severe (≥ 40mmHg or peak velocity 
≥ 4.0 m/s). LVD was classified as moderate (LVEF 36-50%, n=158) or severe (LVEF ≤35%, n=151). Multivariable Cox modeling, which 
included aortic valve replacement as a time dependent covariate was used to assess the relationship between GLS and all-cause mortality.
results:  Baseline GLS was available for 215 (69.6%) patients with moderate AS and 94 (30.4%) patients with severe AS. The median age 
of the cohort was 76 (IQR 67-82) and median EuroSCORE was 9.9 (IQR 5.8-16.6). Median baseline GLS in the overall cohort was -8.7 
(IQR -11 to -6.9); there were no significant differences between patients with moderate (-8.7, IQR -11 to -6.7) or severe AS (-8.8, IQR -10 to 
-7.1), p=0.804. Baseline GLS was worse among patients with severe LVD (-7.4, IQR -9.9 to -6.2) compared with moderate LVD (-9.97, IQR 
-12.1 to -8.3), p<0.001. Baseline GLS was not associated with all-cause mortality in either univariable or multivariable models (HR 0.99, 
95%CI 0.93-1.05). However, higher LVEF (per 5% increase) was associated with decreased mortality in both the univariable (HR 0.92, 95% 
CI 0.85-0.99) and multivariable models (HR 0.83, 95% CI 0.69-0.99).
conclusion:  In patients with pre-existing LVD, baseline GLS does not provide additional value in predicting death. In this cohort of 
adults with moderate to severe AS and LVD, LVEF was a better predictor of all-cause mortality than baseline GLS. Prognostic tools in this 
population need to further explored.
